Optimum Strategic Communications to Host 15th Annual Healthcare Investor Conference

Biotech & Healthcare leaders to share valuable insights on investment priorities and future outlook London, UK, 6 October 2023: Optimum Strategic Communications (Optimum), the international strategic healthcare communications consultancy, will be hosting its 15th Annual Healthcare Investor Conference on Wednesday, 11 October 2023 at the Wellcome Collection, London. 15 years of annual conferences have established the […]

Optimum Hires Senior Journalist Stephen Adams, Former Medical Editor of The Mail on Sunday

London, UK, 15 May 2023 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces the appointment of highly-experienced medical journalist, Stephen Adams, as a full-time member of its team. Stephen, who joins as an Associate Director with immediate effect, spent 10 years at The Mail on Sunday, first as Health Correspondent […]

Optimum Expands its Team with Senior Investor Relations and Communications Hires Jonathan Edwards and Hana Malik

14 February 2023 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces that it has hired Jonathan Edwards and Hana Malik, two highly experienced investor relations and communications professionals, to join as permanent members of its team. Edwards and Malik have joined Optimum as Account Directors and will be advising clients across […]

2022 | Optimum’s Year in Review

It’s nearly the end of 2022! It was an exciting year for Optimum’s clients which demonstrated the resilience and creativity that has made the life sciences industry so successful. We have outlined below a small fraction of the activity that has kept us busy this year: Deal, deals, deals As usual, 2022 was a year […]

LSX and Jefferies – Insights from the busiest week in European biotech 

The LSX Inv€$tival Showcase kicked off a hectic week in life sciences on 15 November, with these two key events in the biotech calendar making one of the busiest weeks of the year.  Investors and biotechs saw this as a vital chance to meet up and discuss strategies and potential deals amid these dicey market […]